TB Breath Test Proposal

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
'''TB Breath Test'''
'''TB Breath Test'''
-
'''Project Overview:''' Developing a novel biosensor device to diagnose tuberculosis infection quickly and efficiently. Our aim is to create an engineered bacterial system to detect volatile compounds in the breath of those infected with tuberculosis, and yield a visible output within minutes.
+
'''Project Overview:''' Developing a novel biosensor device to diagnose tuberculosis infection quickly and efficiently. Our aim is to create an engineered bacterial system to detect unique volatile organic compounds in the breath of those infected with TB and produce a visible output within minutes.
'''Background'''
'''Background'''
Line 10: Line 10:
''Disease background''
''Disease background''
-
-Tuberculosis is an infectious disease caused by ''Mycobacterium tuberculosis''
+
* Tuberculosis is an infectious (potentially fatal) disease caused by the bacteria ''Mycobacterium tuberculosis''
-
-can be fatal
+
* 1/3 of world population is infected; in 2011 alone, 9 million new cases, and nearly 1.4 million TB-related deaths worldwide
-
-usually affects the lungs, but can also affect brain, kidneys, spine
+
* TB usually affects the lungs, but can also affect brain, kidneys, spine
-
-symptoms include weight loss, night sweats, fever, chills, coughing (blood), chest pain
+
** symptoms include coughing (blood), chest pain, weight loss, night sweats, fever, and chills
-
-latent vs active infection
+
* latent vs active infection
-
-becomes active if immune system cannot repress growth
+
** latent infection becomes active if immune system cannot repress bacteria's growth
-
-5-10% of latent cases will become active
+
** 5-10% of latent cases will become active
''2 widely used current tests:''
''2 widely used current tests:''
-
-Mantoux TB skin test injects a small amount of tuberculin into the skin
+
* Mantoux TB skin test injects a small amount of tuberculin into the skin
-
-patient must return to clinic 48/72 hours later for evaluation of injection site
+
** patient must return to clinic 48/72 hours later for evaluation of injection site
 +
 
 +
* TB blood test (interferon-gamma release assay) measures immune system reaction to TB bacteria
-
-TB blood test (interferon-gamma release assay) measures immune system reaction to TB bacteria
 
'''Problem/Goals Statement:'''
'''Problem/Goals Statement:'''
Line 38: Line 39:
''Motivation''
''Motivation''
-
-current TB tests (TB skin test and blood test) are invasive
+
* current TB tests (TB skin test and blood test) are invasive
-
-commonly used TB skin test requires a follow-up visit 48 to 72 hours after tuberculin injection - an inconvenience to both patients and doctors
+
* commonly used TB skin test requires a follow-up visit 48 to 72 hours after tuberculin injection - an inconvenience to both patients and doctors
-
-large need for administering TB tests (please see high-risk characteristics)
+
* large need for administering TB tests (please see high-risk characteristics)
-
-false positives  
+
* false positives  
-
-we would like to propose a better TB detection method that addresses these shortcomings through biological engineering
+
* we propose the creation of a better TB detection method that will address these shortcomings through biological engineering
''Goals''
''Goals''
-
-to detect and concentrate the unique volatile organic compounds (VOC) released from ''Mycobacterium tuberculosis'' in the breath of infected patients
+
* to detect and concentrate the unique volatile organic compounds (VOC) released from ''Mycobacterium tuberculosis'' in the breath of infected patients
-
-to engineer a biological system that amplifies the VOC signal, and quickly produces a visual output
+
* to engineer a biological system that amplifies the VOC signal, and quickly produces a visual output
-
-
+
Line 63: Line 63:
Cambridge Pubic Health Department
Cambridge Pubic Health Department
-
-risk of exposure to active TB (e.g. health care workers)
+
* Test should be used on individuals with:
-
-immigration from TB prominent regions (Africa, Asian, Central and South America, Eastern Europe, the Caribbean, and the Middle East)
+
** risk of exposure to active TB (e.g. health care workers)
-
-abnormal chest X-ray
+
** immigration from TB prominent regions (Africa, Asian, Central and South America, Eastern Europe, the Caribbean, and the Middle East)
-
http://www.cambridgepublichealth.org/services/diseases-conditions/TB-program/index.php
+
** abnormal chest X-ray
 +
* http://www.cambridgepublichealth.org/services/diseases-conditions/TB-program/index.php

Revision as of 22:15, 3 December 2013

20.109 WF Pink Team Research Proposal

TB Breath Test

Project Overview: Developing a novel biosensor device to diagnose tuberculosis infection quickly and efficiently. Our aim is to create an engineered bacterial system to detect unique volatile organic compounds in the breath of those infected with TB and produce a visible output within minutes.

Background


Disease background

  • Tuberculosis is an infectious (potentially fatal) disease caused by the bacteria Mycobacterium tuberculosis
  • 1/3 of world population is infected; in 2011 alone, 9 million new cases, and nearly 1.4 million TB-related deaths worldwide
  • TB usually affects the lungs, but can also affect brain, kidneys, spine
    • symptoms include coughing (blood), chest pain, weight loss, night sweats, fever, and chills
  • latent vs active infection
    • latent infection becomes active if immune system cannot repress bacteria's growth
    • 5-10% of latent cases will become active


2 widely used current tests:

  • Mantoux TB skin test injects a small amount of tuberculin into the skin
    • patient must return to clinic 48/72 hours later for evaluation of injection site
  • TB blood test (interferon-gamma release assay) measures immune system reaction to TB bacteria


Problem/Goals Statement:


Motivation

  • current TB tests (TB skin test and blood test) are invasive
  • commonly used TB skin test requires a follow-up visit 48 to 72 hours after tuberculin injection - an inconvenience to both patients and doctors
  • large need for administering TB tests (please see high-risk characteristics)
  • false positives
  • we propose the creation of a better TB detection method that will address these shortcomings through biological engineering


Goals

  • to detect and concentrate the unique volatile organic compounds (VOC) released from Mycobacterium tuberculosis in the breath of infected patients
  • to engineer a biological system that amplifies the VOC signal, and quickly produces a visual output


Details/Method:

Predicted Outcomes:

Resources:

Cambridge Pubic Health Department

Personal tools